Skip to main content

Advertisement

SpringerLink
Log in

RP-HPLC method validation for fast extraction and quantification of Levonorgestrel drug from silicone based intrauterine device intended for in-process and finished formulation

  • Research article
  • Published:
DARU Journal of Pharmaceutical Sciences Aims and scope Submit manuscript

Abstract

Background

To develop and validate a simple and consistent reversed phase high performance liquid chromatography (RP-HPLC) method for the estimation of Levonorgestrel (LNG) drug from silicone based intrauterine device.

Methods

Sample solution was prepared using tetrahydrofuran (THF) as solvent for the drug extraction, and RP-HPLC analysis was performed using Luna C18 analytical column (150 × 4.6 mm, 5 μm, 100 Å – Phenomenex), with a mobile phase consisting of a mixture of acetonitrile and water (50:50, v/v) at a flow rate of 1.0 ml/min and injection volume of 20 μl. Detection was carried out at 241 nm in PDA detector, with a total run time of 15 min. The method was validated in accordance with ICH guidelines. Method applicability was tested for optimizing formulation using quality-by-design approach, to check the stability and content uniformity of levonorgestrel-silicone mixture (core blend), and quantifying the amount of LNG from commercially available silicone based formulation.

Results

The retention time for LNG drug was obtained at 8.5 min (± 0.3 min). A linear relationship was observed over the concentration range of 2.6–15.6 μg/ml with the correlation coefficient (r) value 0.9999. The method was found to be precise within the acceptable limit (RSD < 2%) and the drug recovery from the intrauterine device was found in the range 99.78–100.0%. Content uniformity for different prototypes developed was observed in the range of 91.6–101.4%, and assay of optimized core blend was in the range of 97.78–106.79% during the 10 days of retention period for stability studies.

Conclusion

The validated method is found to be a simple, accurate, precise, reproducible, and hence can be used for the routine analysis of LNG such as in-process, quality control and stability assays of silicone based intrauterine devices by RP-HPLC.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Scarsi KK, Darin KM, Chappell CA, Nitz SM, Lamorde M. Drug–drug interactions, effectiveness, and safety of hormonal contraceptives in women living with HIV. Drug Saf. 2016;39(11):1053–72. https://doi.org/10.1007/s40264-016-0452-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bao Q, Zou Y, Wang Y, Choi S, Burgess DJ. Impact of product design parameters on in vitro release from intrauterine systems. Int J Pharm. 2020;578:1–10. https://doi.org/10.1016/j.ijpharm.2020.119135.

    Article  CAS  Google Scholar 

  3. Berzas JJ, Rodriguez J, Castaneda G. Simultaneous determination of Ethinylestradiol and Levonorgestrel in oral contraceptives by derivative spectrophotometry. Analyst. 1997;122(1):41–4. https://doi.org/10.1039/A604558H.

    Article  CAS  PubMed  Google Scholar 

  4. Diaz-Cruz MS, Lopez de Alda MJ, Loopez R, Barcelo D. Determination of estrogens and progestogens by mass spectrometric techniques (GC/MS, LC/MS and LC/MS/MS). J Mass Spectrom. 2003;38(9):917–23. https://doi.org/10.1002/jms.529.

    Article  CAS  PubMed  Google Scholar 

  5. Cirrincione LR, Penchala SD, Scarsi KK, Podany AT, Winchester LC, Back DJ, et al. Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1084:106–12. https://doi.org/10.1016/j.jchromb.2018.03.023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Moser C, GschlieBer A, Mattle V, Wildt L, Griesmacher A, Seger C. An ultra-sensitive online SPE-LC-MS/MS method for the quantification of levonorgestrel released from intrauterine devices. Anal Bioanal Chem. 2011;400(8):2655–62. https://doi.org/10.1007/s00216-011-4790-0.

    Article  CAS  PubMed  Google Scholar 

  7. Mohiuddin TM, Islam MD, Latif A, Hassan MM, Hasan MM, Haque P. Analytical method validation of RP-HPLC method for simultaneous estimation of Levonorgestrel and Ethinyl estradiol from combined drug product. Acta Chim Pharm Indica. 2018;8(2):128.

    Google Scholar 

  8. Suhendi A. Validation of high performance of liquid chromatography method for the determination of Levonorgestrel and Ethinyl estradiol in tablets. J Pharm Sci & Res. 2016;8(1):6–9.

    CAS  Google Scholar 

  9. Rathod T, Captain AD. Development and validation of stability indicating RP-HPLC method for simultaneous estimation of Ethinyl estradiol and Levonorgestrel. Int J Pharm Res Anal. 2014;4(3):178–85.

    Google Scholar 

  10. Zaidi I, Joshi D, Bhadauria RS. Method development and analytical validation of Levonorgestrel drug by RP-HPLC – a research article. Int J Adv Res Pharm Biosci. 2014;4(1):1–10.

    CAS  Google Scholar 

  11. Ravindra A, Hima P, Swamy KN, Kumar KV. Validated RP-HPLC method for simultaneous estimation of Levonorgestrel and Ethinylestradiol in combined dosage form. J Sci Innov Res. 2013;2(3):642–50.

    Google Scholar 

  12. Prasad SD, Reddy GC, Prasad PSS, Mukkanti K. Simultaneous HPLC estimation of Levonorgestrel and Ethinylestradiol from tablets. Indian J Pharm Sci. 2004;66(2):231–4.

    CAS  Google Scholar 

  13. Santoro MIRM, Kassab NM, Hasegawa M, Kedor-Hackmann ERM. Determination of steroid hormones in Oral contraceptives by high-performance liquid chromatography. Drug Dev Ind Pharm. 2002;28(6):741–7. https://doi.org/10.1081/DDC-120003866.

    Article  CAS  PubMed  Google Scholar 

  14. Prabhakar B, Deshpande SG. Simultaneous estimation of Ethinyl estradiol and Levonorgestrel from transdermal patches by HPLC. Indian J Pharm Sci. 1999;61(1):12–5.

    CAS  Google Scholar 

  15. Bao Q, Gu B, Price CF, Zou Y, Wang Y, Kozak D, et al. Manufacturing and characterization of long-acting levonorgestrel intrauterine systems. Int J Pharm. 2018;550(1–2):447–54. https://doi.org/10.1016/j.ijpharm.2018.09.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology, Q2 (R1). 2005;4:1–13.

  17. Ye W-P, Chien YW. Dual-controlled drug delivery across biodegradable copolymer. II. Delivery kinetics of levonorgestrel and estradiol from (matrix/matrix) laminate drug delivery system. J Control Release. 1996;41(3):259–69. https://doi.org/10.1016/0168-3659(96)01330-2.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge HLL Lifecare Limited, Trivandrum, Kerala, India for financial support and for providing research facilities.

Author information

Authors and Affiliations

  1. Corporate Research and Development Centre, HLL Lifecare Limited, Akkulam, Sreekariyam, Trivandrum, Kerala, 695017, India

    Midhu George Veeran, Karthikeyan C., Bharaniraja B., Diksha Painuly & Abi Santhosh Aprem

Authors
  1. Midhu George Veeran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karthikeyan C.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bharaniraja B.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Diksha Painuly
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abi Santhosh Aprem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Diksha Painuly.

Ethics declarations

Competing interests

The authors declare that there are no conflicts of interest regarding the publication of this research work.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 322 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Veeran, M.G., C., K., B., B. et al. RP-HPLC method validation for fast extraction and quantification of Levonorgestrel drug from silicone based intrauterine device intended for in-process and finished formulation. DARU J Pharm Sci 29, 185–193 (2021). https://doi.org/10.1007/s40199-021-00396-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40199-021-00396-7

Keywords

Search

Navigation